- Lobbying
- Krista AND Drobac
Lobbying Arrangements Results for 'Krista Drobac'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details S.2973 - Modernizing and Ensuring PBM Accountability Act |
Orsini Specialty Pharmacy
specialty pharmacy |
Sirona Strategies LLC | |||
Details Remote patient monitoring. |
Intel
|
Sirona Strategies, LLC | |||
Details Serious mental illness. |
Magellan Health, Inc.
|
Sirona Strategies LLC | |||
Details Medicare policies related to remote patient monitoring; care in the home. |
Cadence
|
Sirona Strategies LLC | |||
Details Implementation of the Patient Protection and Affordable Care Act (Pub. L. No. 111-148) |
Booz Allen Hamilton
|
Sirona Strategies LLC | |||
Details Opioids. |
Maximus, Inc.
|
Sirona Strategies LLC | |||
Details Telehealth reimbursement issues for critical access hospitals; H.R. 2228, Rural Behavioral Health Access Act; Protecting Rural Telehealth Access Act; tele-mental health legislation. |
Psychiatric Medical Care
|
Sirona Strategies LLC | |||
Details Support for expansion of the Medicare Diabetes Prevention Program (DPP). |
Omada Health
|
Sirona Strategies LLC | |||
Details Medicare Advantage risk adjustment. |
CenseoHealth
|
DLA Piper LLP (US) | |||
Details Urgent care center distribution of COVID-19 vaccine. |
Experity Health
|
Sirona Strategies LLC | |||
Details Digital quality measures legislation. |
National Committee for Quality Assurance
|
Sirona Strategies LLC | |||
Details Medicare Advantage; H.R. 2131, Medicare Advantage Quality Payment Relief Act of 2019; drug pricing. |
Alliance of Community Health Plans
|
Sirona Strategies LLC | |||
Details Issues pertaining to health savings accounts. |
ArmadaGlobal
|
Sirona Strategies LLC | |||
Details Value-based care; new payment and delivery models. |
Landmark Health
|
Sirona Strategies LLC | |||
Details Hospital at Home; Hospital at Home (H.R. 2853) Expanding Care in the Home |
Moving Health Home
|
Sirona Strategies LLC | |||
Details Modernize federal policies regarding telehealth and remote patient monitoring. |
Alliance for Connected Care
|
DLA Piper LLP (US) | |||
Details Implementation of Public Law No. 111-148. |
Fresenius Medical Care
|
DLA Piper LLP (US) | |||
Details Health care financing. |
Coalition on Health Care
|
DLA Piper LLP (US) | |||
Details Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; prescription drug abuse. Issues related to Medicare/Medicaid reimbursements. |
Pfizer, Inc.
|
DLA Piper LLP (US) | |||
Details Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program. |
Blue Cross and Blue Shield Association
|
DLA Piper LLP (US) | |||
Details Telehealth, Mental Health, Medicare Advantage |
Signify Health (f/k/a Censeo Health)
|
Sirona Strategies LLC | |||
Details Implementation of Public Law No. 111-148, provisions related to health IT. |
Aetna, Inc.
|
DLA Piper LLP (US) | |||
Details Issues related to Medicare and Medicaid reimbursements. |
National Association for Home Care and Hospice
|
DLA Piper LLP (US) | |||
Details Understand Act, LINC to address Social Needs Act; Social Determinants Accelerator Act; Health Center Community Transformation Hub Act; LINC for VA Act; Hub Act; Kids Health Act. |
Aligning for Health
|
Sirona Strategies LLC | |||
Details Remote patient monitoring; Medicare telehealth extension; provider location issues Remote patient monitoring; Medicare telehealth extension; provider location issues. |
Alliance for Connected Care
|
Sirona Strategies LLC | |||
Details H.R. 4350, National Defense Authorization Act for FY2022, provisions on artificial intelligence and information technology. H.R. 4432, Department of Defense Appropriations Act, FY2022, provisions o... |
Booz Allen Hamilton
|
DLA Piper LLP (US) | |||
Details Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S... |
Novo Nordisk Inc.
|
DLA Piper LLP (US) |